- Conditions
- Prematurity, Respiratory Distress Syndrome, Patent Ductus Arteriosus
- Interventions
- Survanta (beractant), Curosurf (poractant)
- Drug
- Lead sponsor
- Alan Fujii
- Other
- Eligibility
- Up to 8 Hours
- Enrollment
- 52 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2009
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 25–44
of 44
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Ductus Arteriosus, Patent
- Interventions
- Percutaneous Patent Ductus Arteriosus Closure (PPC), Responsive Management Intervention, Echocardiogram, cardiac
- Device · Combination Product · Diagnostic Test
- Lead sponsor
- Nationwide Children's Hospital
- Other
- Eligibility
- 7 Days to 32 Days
- Enrollment
- 240 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2023 – 2026
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • Little Rock, Arkansas • Los Angeles, California + 19 more
- Conditions
- Aortic Coarctation, Cardiomyopathy, Atrial Septal Defect, Aortic Stenosis, Post Heart Transplant Catheter Procedure, Patent Ductus Arteriosus
- Interventions
- MRI guided cardiac catheterization, Magnetic resonance imaging
- Procedure · Device
- Lead sponsor
- Joshua Kanter
- Other
- Eligibility
- Not listed
- Enrollment
- 50 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2024
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Not listed
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 3 Months
- Enrollment
- 350 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2014
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Patent Ductus Arteriosus
- Interventions
- ADO II AS (PDA closure)
- Device
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 3 Days and older
- Enrollment
- 200 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2022
- U.S. locations
- 9
- States / cities
- Los Angeles, California • Orlando, Florida • Detroit, Michigan + 6 more
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Acetaminophen, Ibuprofen
- Drug
- Lead sponsor
- Albany Medical College
- Other
- Eligibility
- 1 Minute to 2 Weeks
- Enrollment
- 10 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2017 – 2019
- U.S. locations
- 1
- States / cities
- Albany, New York
- Conditions
- Patent Ductus Arteriosus, Prematurity
- Interventions
- Ibuprofen
- Drug
- Lead sponsor
- University of Utah
- Other
- Eligibility
- Up to 96 Hours
- Enrollment
- 15 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 1
- States / cities
- Salt Lake City, Utah
- Conditions
- Patent Ductus Arteriosus
- Interventions
- feeding, fasting
- Other
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 23 Weeks to 33 Weeks
- Enrollment
- 177 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 14
- States / cities
- San Francisco, California • San Jose, California • Chicago, Illinois + 11 more
- Conditions
- Coarctation of the Aorta, Aortic Arch Obstruction
- Interventions
- Monitoring using resonance Raman spectroscopy, pulse oximetry, blood pressure, and near-infrared spectroscopy
- Device
- Lead sponsor
- Boston Children's Hospital
- Other
- Eligibility
- 0 Days to 60 Days
- Enrollment
- 60 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2023 – 2026
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Ductus Arteriosus, Patent
- Interventions
- Transcatheter PDA Coil
- Device
- Lead sponsor
- PFM Medical, Inc
- Industry
- Eligibility
- 6 Months to 21 Years
- Enrollment
- 357 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2002 – 2007
- U.S. locations
- 15
- States / cities
- Los Angeles, California • Madera, California • Orange, California + 12 more
- Conditions
- Infant, Premature, Congenital Heart Disease, Patent Ductus Arteriosus, Necrotizing Enterocolitis
- Interventions
- Near-infrared spectroscopy (NIRS)
- Procedure
- Lead sponsor
- University of Utah
- Other
- Eligibility
- 12 Days to 6 Months
- Enrollment
- 64 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2022
- U.S. locations
- 3
- States / cities
- Murray, Utah • Salt Lake City, Utah
- Conditions
- Patent Ductus Arteriosus, Surgery, Necrotizing Enterocolitis, Intestinal Perforation
- Interventions
- pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID
- Other · Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 5 Days to 14 Days
- Enrollment
- 202 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2013 – 2017
- U.S. locations
- 13
- States / cities
- San Diego, California • San Francisco, California • San Jose, California + 9 more
- Conditions
- Congenital Heart Disease, Congenital Heart Disease (CHD)
- Interventions
- Ductus Arteriosus Stent
- Device
- Lead sponsor
- Starlight Cardiovascular Inc
- Industry
- Eligibility
- 1 Minute to 6 Months
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 10
- States / cities
- Los Angeles, California • San Diego, California • Stanford, California + 7 more
- Conditions
- Ductus Arteriosus, Patent
- Interventions
- Nondisclosure of screening echocardiogram results, Disclosure of screening echocardiogram results
- Other
- Lead sponsor
- University of Pennsylvania
- Other
- Eligibility
- Up to 72 Hours
- Enrollment
- 88 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2009 – 2011
- U.S. locations
- 2
- States / cities
- Philadelphia, Pennsylvania
- Conditions
- Patent Ductus Arteriosus
- Interventions
- INVOS Cerebral/Somatic oximeter
- Device
- Lead sponsor
- University of Louisville
- Other
- Eligibility
- Not listed
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2007 – 2009
- U.S. locations
- 1
- States / cities
- Lousiville, Kentucky
- Conditions
- PDA, Low; Birthweight, Extremely (999 Grams or Less)
- Interventions
- Not listed
- Lead sponsor
- Pediatrix
- Other
- Eligibility
- Not listed
- Enrollment
- 208 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2016 – 2021
- U.S. locations
- 2
- States / cities
- Mesa, Arizona • Phoenix, Arizona
- Conditions
- Patent Ductus Arteriosus, Neonate
- Interventions
- Acetaminophen, ibuprofen
- Drug
- Lead sponsor
- University of Florida
- Other
- Eligibility
- 23 Weeks to 30 Weeks
- Enrollment
- 20 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2017 – 2019
- U.S. locations
- 2
- States / cities
- Jacksonville, Florida
- Conditions
- Patent Ductus Arteriosus (PDA)
- Interventions
- Device closure with AMPLATZER Duct Occluder, Objective Performance Criteria
- Device · Other
- Lead sponsor
- Abbott Medical Devices
- Industry
- Eligibility
- 6 Months to 18 Years
- Enrollment
- 436 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 1999 – 2009
- U.S. locations
- 24
- States / cities
- Birmingham, Alabama • San Diego, California • Denver, Colorado + 21 more
- Conditions
- Patent Ductus Arteriosus
- Interventions
- Indomethacin, Acetaminophen
- Drug
- Lead sponsor
- University of Tennessee
- Other
- Eligibility
- 22 Weeks to 32 Weeks
- Enrollment
- 37 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2016 – 2018
- U.S. locations
- 3
- States / cities
- Memphis, Tennessee
- Conditions
- Gastroesophageal Reflux, Presumed Sepsis, Patent Ductus Arteriosus, Chronic Lung Disease, Neurodevelopmental Impairment
- Interventions
- Not listed
- Lead sponsor
- Duke University
- Other
- Eligibility
- Up to 5 Days
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2010 – 2013
- U.S. locations
- 1
- States / cities
- Durham, North Carolina